Ensysce Biosciences Inc (ENSC) — Financial Flexibility Index
Ensysce Biosciences Inc (ENSC) has a Financial Flexibility Index of -0.48x as of June 2026. Free cash flow of $-1.96 Million (operating CF $-1.96 Million minus capex $0.00) represents 0% of total liabilities ($4.07 Million). Check cash flow reinvestment rate of Ensysce Biosciences Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ensysce Biosciences Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Ensysce Biosciences Inc across 9 annual periods. For the full cash flow conversion analysis, see Ensysce Biosciences Inc (ENSC) cash flow conversion.
Annual Financial Flexibility Index for Ensysce Biosciences Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Ensysce Biosciences Inc. Explore Ensysce Biosciences Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.68x | $-7.68 Million | $-7.81 Million | $4.57 Million | ▲ +50.3% |
| 2024 | -3.38x | $-7.50 Million | $-7.50 Million | $2.22 Million | ▼ -5.4% |
| 2023 | -3.21x | $-10.78 Million | $-10.78 Million | $3.36 Million | ▼ -77.9% |
| 2022 | -1.80x | $-17.89 Million | $-17.89 Million | $9.91 Million | ▼ -437.9% |
| 2021 | -0.34x | $-8.24 Million | $-8.24 Million | $24.58 Million | ▼ -88.5% |
| 2020 | -0.18x | $-1.25 Million | $-1.25 Million | $7.01 Million | ▼ -116.7% |
| 2019 | 1.06x | $10.99 Million | $10.99 Million | $10.34 Million | ▲ +739.0% |
| 2018 | -0.17x | $-1.24 Million | $-1.24 Million | $7.44 Million | ▼ -373.0% |
| 2017 | -0.04x | $-251.83K | $-251.83K | $7.16 Million | — |